Description
FOXO4-DRI is the D-retro-inverso variant of a FOXO4 peptide designed to disrupt the FOXO4-p53 interaction in senescent cells. In preclinical models, FOXO4-DRI promotes apoptosis specifically in p21-positive senescent cells, making it a key tool compound for studying senolytics, healthspan biology, and cellular senescence clearance pathways in ageing research.
Available as 10 mg lyophilized at ≥98% HPLC purity with COA.
| Format | Lyophilized powder |
|---|---|
| Purity | ≥98% HPLC |
| Storage | −20°C desiccated |
Research Use Only. Not for human or veterinary use.




